Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment

There are limited data available about the durability of the immune response after administration of the widely used adenovirus-vectored ChAdOx1-nCoV-19 vaccine in cancer patients. This prospective longitudinal observational study analyzed follow-up data of immunogenic responses 12 weeks after the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanchaijiraboon, Passakorn, Teeyapun, Nattaya, Pakvisal, Nussara, Sainamthip, Panot, Susiriwatananont, Thiti, Zungsontiporn, Nicha, Suntronwong, Nungruthai, Vichaiwattana, Preeyaporn, Klinsawat, Worata, Wanlapakorn, Nasamon, Tanasanvimon, Suebpong, Sriuranpong, Virote, Poovorawan, Yong, Luangdilok, Sutima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609471/
https://www.ncbi.nlm.nih.gov/pubmed/36298528
http://dx.doi.org/10.3390/vaccines10101662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609471/
https://www.ncbi.nlm.nih.gov/pubmed/36298528
http://dx.doi.org/10.3390/vaccines10101662

Ejemplares similares